Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Flexible peritoneal windows for quantitative fluorescence and bioluminescence preclinical imaging.

Souris JS, Hickson JA, Msezane L, Rinker-Schaeffer CW, Chen CT.

Mol Imaging. 2013 Jan-Feb;12(1):28-38.

PMID:
23348789
2.

Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization.

Bainer RO, Veneris JT, Yamada SD, Montag A, Lingen MW, Gilad Y, Rinker-Schaeffer CW.

Clin Exp Metastasis. 2012 Jun;29(5):397-408. doi: 10.1007/s10585-011-9448-y. Epub 2012 Feb 21.

3.

Building on the foundation of daring hypotheses: using the MKK4 metastasis suppressor to develop models of dormancy and metastatic colonization.

Knopeke MT, Ritschdorff ET, Clark R, Vander Griend DJ, Khan S, Thobe M, Shear JB, Rinker-Schaeffer CW.

FEBS Lett. 2011 Oct 20;585(20):3159-65. doi: 10.1016/j.febslet.2011.09.007. Epub 2011 Sep 12.

4.

From prostate to bone: key players in prostate cancer bone metastasis.

Thobe MN, Clark RJ, Bainer RO, Prasad SM, Rinker-Schaeffer CW.

Cancers (Basel). 2011;3(1):478-93. doi: 10.3390/cancers3010478.

5.

Metastasis-suppressor genes in clinical practice: lost in translation?

Shoushtari AN, Szmulewitz RZ, Rinker-Schaeffer CW.

Nat Rev Clin Oncol. 2011 Jun;8(6):333-42. doi: 10.1038/nrclinonc.2011.65. Epub 2011 Apr 26. Review.

PMID:
21522123
6.

Thinking outside the box: using metastasis suppressors as molecular tools.

Thiolloy S, Rinker-Schaeffer CW.

Semin Cancer Biol. 2011 Apr;21(2):89-98. doi: 10.1016/j.semcancer.2010.12.008. Epub 2010 Dec 13. Review.

PMID:
21147228
7.

Disrupting ovarian cancer metastatic colonization: insights from metastasis suppressor studies.

Khan S, Taylor JL, Rinker-Schaeffer CW.

J Oncol. 2010;2010:286925. doi: 10.1155/2010/286925. Epub 2010 Mar 14.

8.

In vitro metastatic colonization of human ovarian cancer cells to the omentum.

Khan SM, Funk HM, Thiolloy S, Lotan TL, Hickson J, Prins GS, Drew AF, Rinker-Schaeffer CW.

Clin Exp Metastasis. 2010 Mar;27(3):185-96. doi: 10.1007/s10585-010-9317-0. Epub 2010 Mar 14.

PMID:
20229256
9.

New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells.

Taylor JL, Szmulewitz RZ, Lotan T, Hickson J, Griend DV, Yamada SD, Macleod K, Rinker-Schaeffer CW.

Cancer Lett. 2008 Dec 8;272(1):12-22. doi: 10.1016/j.canlet.2008.05.012. Epub 2008 Jun 24. Review.

PMID:
18572308
10.

c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.

Lotan T, Hickson J, Souris J, Huo D, Taylor J, Li T, Otto K, Yamada SD, Macleod K, Rinker-Schaeffer CW.

Cancer Res. 2008 Apr 1;68(7):2166-75. doi: 10.1158/0008-5472.CAN-07-1568.

11.

Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines.

Robinson VL, Shalhav O, Otto K, Kawai T, Gorospe M, Rinker-Schaeffer CW.

Mol Cancer Res. 2008 Mar;6(3):501-8. doi: 10.1158/1541-7786.MCR-07-2075.

12.

Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia.

Lotan TL, Lyon M, Huo D, Taxy JB, Brendler C, Foster BA, Stadler W, Rinker-Schaeffer CW.

J Pathol. 2007 Aug;212(4):386-94.

PMID:
17577251
13.

Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application.

Rinker-Schaeffer CW, O'Keefe JP, Welch DR, Theodorescu D.

Clin Cancer Res. 2006 Jul 1;12(13):3882-9. Review. No abstract available.

14.

The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.

Hickson JA, Huo D, Vander Griend DJ, Lin A, Rinker-Schaeffer CW, Yamada SD.

Cancer Res. 2006 Feb 15;66(4):2264-70.

15.

Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.

Vander Griend DJ, Kocherginsky M, Hickson JA, Stadler WM, Lin A, Rinker-Schaeffer CW.

Cancer Res. 2005 Dec 1;65(23):10984-91.

16.

An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis.

Luu HH, Kang Q, Park JK, Si W, Luo Q, Jiang W, Yin H, Montag AG, Simon MA, Peabody TD, Haydon RC, Rinker-Schaeffer CW, He TC.

Clin Exp Metastasis. 2005;22(4):319-29.

PMID:
16170668
17.

Metastasis suppressor genes: from gene identification to protein function and regulation.

Berger JC, Vander Griend DJ, Robinson VL, Hickson JA, Rinker-Schaeffer CW.

Cancer Biol Ther. 2005 Aug;4(8):805-12. Review.

PMID:
16082183
18.

Adjunctive therapy for men with high risk localized and locally advanced prostate cancer: targeting disseminated tumor cells.

Sokoloff MH, Rinker-Schaeffer CW, Chung LW, Brendler CB.

J Urol. 2004 Dec;172(6 Pt 2):2539-44. Review.

PMID:
15538203
19.

The basic biology of metastasis.

Robinson VL, Kauffman EC, Sokoloff MH, Rinker-Schaeffer CW.

Cancer Treat Res. 2004;118:1-21. Review. No abstract available.

PMID:
15043186
20.

A new look at an old problem: the survival and organ-specific growth of metastases.

Vander Griend DJ, Rinker-Schaeffer CW.

Sci STKE. 2004 Jan 13;2004(216):pe3. Review.

PMID:
14734785

Supplemental Content

Loading ...
Support Center